Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Procarbazine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4 CNS 1

Conditions

Central Nervous System Neoplasms 16 Astrocytoma 11 Oligodendroglioma 10 Glioblastoma 9 Brain Neoplasms 9 Gliosarcoma 7 Glioma 6 Recurrence 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Medulloblastoma 1 Lymphoma 1 Familial ependymoma 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Temozolomide 22 Bevacizumab 18 Cyclophosphamide 7 Lomustine 6 Irinotecan 6 Carboplatin 6 3-Iodobenzylguanidine 6 Topotecan 5 Radiotherapy 5 Radiosurgery 4 Nivolumab 4 Filgrastim 4 Everolimus 4 fludarabine phosphate 3 Vincristine 3 Sirolimus 3 IL13-PE38 3 Etoposide 3 Drug Therapy 3 Busulfan 3 Antilymphocyte Serum 3 thymoglobulin 2 sonidegib 2 ribociclib 2 pembrolizumab 2 paclitaxel-Angiopep-2 conjugate 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

Incheon St.Mary's Hospital

Phase 2 Unknown

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡